• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AXIOS; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AXIOS; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE Back to Search Results
Model Number M00553640
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Injury (2348); No Code Available (3191)
Event Date 01/17/2020
Event Type  Injury  
Manufacturer Narrative
The complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.(b)(6).(b)(4).The complainant indicated that the device has been disposed and will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that a hot axios stent was implanted in a transgastric position to treat a pancreatic pseudocyst during a hot axios placement procedure on (b)(6) 2019.The axios stent was implanted successfully without issues and the procedure was completed by placing an additional double pigtail stent and drainage was successful.Reportedly, on (b)(6) 2020, it was noted that the patient had moderate black stool.The patient was hospitalized and a transfusion was performed.On (b)(6) 2020, no issues were noted with the hot axis stent, placement was still correct and the stent was in an open state.The hot axios stent was removed from the patient without issue on this date.On (b)(6) 2020 it was noted that the patient's condition improved.On (b)(6) 2020 a follow-up was conducted 7 days after removal and there were no adverse events to the patient.In the physician's opinion the adverse event has a causal relationship with this device.There were no alleged deficiencies or issues reported with the hot axios itself.Attempts to obtain additional information regarding the circumstances surrounding this event have been unsuccessful to date.Should additional relevant details become available, a supplemental report will be submitted.
 
Event Description
It was reported to boston scientific corporation that a hot axios stent was implanted in a transgastric position to treat a pancreatic pseudocyst during a hot axios placement procedure on (b)(6), 2019.The axios stent was implanted successfully without issues and the procedure was completed by placing an additional double pigtail stent and drainage was successful.Reportedly, on (b)(6), 2020, it was noted that the patient had moderate black stool.The patient was hospitalized and a transfusion was performed.On (b)(6), 2020, no issues were noted with the hot axis stent, placement was still correct and the stent was in an open state.The hot axios stent was removed from the patient without issue on this date.On (b)(6), 2020 it was noted that the patient's condition improved.On (b)(6) 2020 a follow-up was conducted 7 days after removal and there were no adverse events to the patient.In the physician's opinion the adverse event has a causal relationship with this device.There were no alleged deficiencies or issues reported with the hot axios itself.Attempts to obtain additional information regarding the circumstances surrounding this event have been unsuccessful to date.Should additional relevant details become available, a supplemental report will be submitted.***additional information received on (b)(6)2020*** the reported hospitalization and transfusion was performed as treatment for the black stool.The patient was reported to be recovering.It was reported that the patient had an underlying splenic aneurism that may have contributed to the black stool.
 
Manufacturer Narrative
Block b5 has been updated with additional information received.Block h11: block h6 patient code has been corrected.Block d4, h4: the complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.However, it was reported that the device was not used past the expiration date.Block g3: e7121 axios japan post market survey block h6: patient code 1888 captures the reported black stool.Patient code 3191 captures hospitalization and transfusion performed.Block h10: the complainant indicated that the device has been disposed and will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIOS
Type of Device
PANCREATIC STENT, COVERED, METALLIC, REMOVABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key9874143
MDR Text Key189609448
Report Number3005099803-2020-01234
Device Sequence Number1
Product Code PCU
UDI-Device Identifier08714729904588
UDI-Public08714729904588
Combination Product (y/n)N
PMA/PMN Number
K153088
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM00553640
Device Catalogue Number5364
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/02/2020
Initial Date FDA Received03/24/2020
Supplement Dates Manufacturer Received03/24/2020
Supplement Dates FDA Received04/14/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age57 YR
Patient Weight87
-
-